Open Innovation Partners   Report issue

For profit Phase 1
Founded: Cork Ireland (2011)

Organization Overview

First Clinical Trial
2019
NCT03859752
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Open Innovation Partners

Active Ingredients

Drugs in Phase 1 Trials (1)

tr1801-adc (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1